NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球代謝紊亂治療市場規模調查:按給藥途徑、疾病、治療類型和地區預測(2021-2027)

Global Metabolic Disorder Therapeutics Market Size study, by Route of Administration, by Disease, by Therapy Type, and Regional Forecasts 2021-2027

出版商 Bizwit Research & Consulting LLP 商品編碼 1014114
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
全球代謝紊亂治療市場規模調查:按給藥途徑、疾病、治療類型和地區預測(2021-2027) Global Metabolic Disorder Therapeutics Market Size study, by Route of Administration, by Disease, by Therapy Type, and Regional Forecasts 2021-2027
出版日期: 2021年06月11日內容資訊: 英文
簡介

2020年全球代謝紊亂市場將達到約601.6億美元。

在 2021-2027 年的預測期內,市場預計將以超過 7.30% 的健康增長率增長。

當體內異常的化學反應破壞了從消化食物中獲取能量的過程時,就會發生代謝紊亂。代謝紊亂治療意識的提高以及新研究和技術的進步正在推動代謝紊亂市場的發展。各種代謝紊亂,尤其是肥胖症和糖尿病的發病率不斷增加,也推動了代謝紊亂治療市場的發展。

根據世界衛生組織的數據,2019 年全球估計有 150 萬人死於糖尿病。 2012年增加到220萬。 2019 年,國際糖尿病聯盟將有大約 4.36 億成年人(20-79 歲)患有糖尿病。預計到 2045 年將達到 7 億。大多數國家的 2 型糖尿病患者比例正在增加,79% 的糖尿病患者生活在低收入和中等收入國家。全世界有超過 110 萬兒童和青少年患有 1 型糖尿病。一些罕見疾病治療的高成本和缺乏明確的監管政策預計將抑制市場增長。然而,COVID-19 大流行後肥胖的不利影響以及人們對良好新陳代謝重要性的日益認識預計將成為未來十年代謝紊亂治療市場的機會。

本報告調查了全球代謝紊亂治療市場,並按給藥途徑、疾病、治療類型、地區和進入市場的公司概況提供了市場概況以及趨勢。

目錄

第 1 章執行摘要

第二章全球代謝紊亂藥物市場的定義和範圍

第 3 章全球代謝紊亂治療藥物市場動態

  • 代謝紊亂藥物市場影響分析(2019-2027)

第 4 章全球代謝紊亂治療藥物市場行業分析

  • 波特的 5 力模型
  • PEST 分析
  • 招商招商模式
  • 分析師建議和結論

第 5 章按疾病分類的全球代謝紊亂治療藥物市場

  • 市場快照
  • 全球代謝紊亂治療市場,按疾病分類:性能-潛力分析
  • 全球代謝紊亂藥物市場的估計和預測,按疾病分類:2018-2027(10億美元)
  • 代謝紊亂治療藥物市場,細分市場分析
    • 溶□體貯積病
    • 糖尿病
    • 肥胖
    • 先天性代謝錯誤
    • 高膽固醇血症

第 6 章全球代謝紊亂治療藥物市場,按給藥途徑

  • 市場快照
  • 全球代謝紊亂治療市場,按給藥途徑:性能-潛力分析
  • 全球代謝紊亂藥物市場預估及預測,按給藥途徑:2018-2027(10億美元)
  • 代謝紊亂治療藥物市場,細分市場分析
    • 口服給藥
    • 腸胃外給藥
    • 其他

第 7 章全球代謝紊亂治療藥物市場,按治療類型

  • 市場快照
  • 全球代謝紊亂治療市場,按治療類型:性能-潛力分析
  • 全球代謝紊亂藥物市場的估計和預測,按治療類型:2018-2027(10億美元)
  • 代謝紊亂治療藥物市場,細分市場分析
    • □替代療法
    • 細胞移植
    • 小分子療法
    • 底物減量療法
    • 基因治療
    • 藥物治療

第 8 章全球代謝紊亂藥物市場,區域分析

  • 區域市場快照
  • 北美
    • 美國
    • 加拿大
  • 歐洲快照
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他
  • 亞太地區快照
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他
  • 拉丁美洲快照
    • 巴西
    • 墨西哥
  • 其他領域

第9章衝突信息

  • 頂級市場策略
  • 公司簡介
  • 諾和諾德
    • Eli Lilly and Company
    • Shire Plc
    • Sanofi
    • Merck KGaA
    • AstraZeneca
    • AbbVie Inc.,
    • Actelion Pharmaceuticals Ltd
    • Amgen Inc.,
    • Biocon

第10章 調查流程

目錄

Global Metabolic Disorder Therapeutics Market is valued approximately USD 60.16 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 7.30% over the forecast period 2021-2027. Metabolic disorder occurs when abnormal chemical reactions in the body disrupt the process of making energy from the digested food. The rising awareness for the treatment of metabolic disorders and the new research and technological advancements are propelling the Metabolic Disorder Therapeutics market. The rising incidences of various metabolic disorders, especially obesity and diabetes, are also driving the Metabolic Disorder Therapeutics market. According to World Health Organization, an estimated 1.5 million deaths were directly caused by diabetes globally in 2019. Another 2.2 million deaths were attributable to high blood glucose in 2012. In 2019, International Diabetes Federation reports that approximately 463 million adults (20-79 years) were living with diabetes which will rise to 700 million in 2045. Proportion of people with type 2 diabetes is increasing in most countries, with 79% of adults with diabetes living in low- and middle-income countries. More than 1.1 million children and adolescents are living with type 1 diabetes worldwide. The expensive nature of some therapies for rare diseases as well as lack of unequivocal regulatory policies may act as a restraint for its growth. However, increasing awareness for harmful effects of obesity and importance of good metabolism after COVID-19 pandemic acts as an opportunity for Metabolic Disorder Therapeutics Market in subsequent decade.

Key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World are analysed to provide a holistic picture of Metabolic Disorder Therapeutics Market. Due to higher expenditure on healthcare as well as higher per capita income, North America has emerged as the significant region across the world in terms of market share. Whereas, Asia-Pacific is expected to exhibit the highest growth rate for the forecast period 2021-2027 owing to the rising disposable income and growing incidences of diabetes and obesity along with other metabolic disorders in the region.

Major market player included in this report are:

Novo Nordisk

Eli Lilly and Company

Shire Plc

Sanofi

Merck KGaA

AstraZeneca

AbbVie Inc.,

Actelion Pharmaceuticals Ltd

Amgen Inc.,

Biocon

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Disease:

Lysosomal Storage Diseases

Diabetes

Obesity

Inherited Metabolic Disorders

Hypercholesterolemia

By Route of Administration:

Oral Administration

Parenteral Administration

Other route of administration

By Therapy Type:

Enzyme Replacement Therapy

Cellular Transplantation

Small Molecule-Based Therapy

Substrate Reduction Therapy

Gene Therapy

Drug Therapy

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019

Base year - 2020

Forecast period - 2021 to 2027

Target Audience of the Global Metabolic Disorder Therapeutics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1.Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
    • 1.2.1. Metabolic Disorder Therapeutics Market, by Disease, 2019-2027 (USD Billion)
    • 1.2.2. Metabolic Disorder Therapeutics Market, by Route of Administration, 2019-2027 (USD Billion)
    • 1.2.3. Metabolic Disorder Therapeutics Market, by Therapy Type, 2019-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Metabolic Disorder Therapeutics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Metabolic Disorder Therapeutics Market Dynamics

  • 3.1. Metabolic Disorder Therapeutics Market Impact Analysis (2019-2027)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidences of diabetes and obesity
      • 3.1.1.2. Research and development in the field therapy
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of treatment of rare diseases
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increased expenditure from government and international bodies

Chapter 4. Global Metabolic Disorder Therapeutics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Metabolic Disorder Therapeutics Market, by Disease

  • 5.1. Market Snapshot
  • 5.2. Global Metabolic Disorder Therapeutics Market by Disease, Performance - Potential Analysis
  • 5.3. Global Metabolic Disorder Therapeutics Market Estimates & Forecasts by Disease 2018-2027 (USD Billion)
  • 5.4. Metabolic Disorder Therapeutics Market, Sub Segment Analysis
    • 5.4.1. Lysosomal Storage Diseases
    • 5.4.2. Diabetes
    • 5.4.3. Obesity
    • 5.4.4. Inherited Metabolic Disorders
    • 5.4.5. Hypercholesterolemia

Chapter 6. Global Metabolic Disorder Therapeutics Market, by Route of Administration

  • 6.1. Market Snapshot
  • 6.2. Global Metabolic Disorder Therapeutics Market by Route of Administration, Performance - Potential Analysis
  • 6.3. Global Metabolic Disorder Therapeutics Market Estimates & Forecasts by Route of Administration 2018-2027 (USD Billion)
  • 6.4. Metabolic Disorder Therapeutics Market, Sub Segment Analysis
    • 6.4.1. Oral Administration
    • 6.4.2. Parenteral Administration
    • 6.4.3. Other route of administration

Chapter 7. Global Metabolic Disorder Therapeutics Market, by Therapy Type

  • 7.1. Market Snapshot
  • 7.2. Global Metabolic Disorder Therapeutics Market by Therapy Type, Performance - Potential Analysis
  • 7.3. Global Metabolic Disorder Therapeutics Market Estimates & Forecasts by Therapy Type 2018-2027 (USD Billion)
  • 7.4. Metabolic Disorder Therapeutics Market, Sub Segment Analysis
    • 7.4.1. Enzyme Replacement Therapy
    • 7.4.2. Cellular Transplantation
    • 7.4.3. Small Molecule-Based Therapy
    • 7.4.4. Substrate Reduction Therapy
    • 7.4.5. Gene Therapy
    • 7.4.6. Drug Therapy

Chapter 8. Global Metabolic Disorder Therapeutics Market, Regional Analysis

  • 8.1. Metabolic Disorder Therapeutics Market, Regional Market Snapshot
  • 8.2. North America Metabolic Disorder Therapeutics Market
    • 8.2.1. U.S. Metabolic Disorder Therapeutics Market
      • 8.2.1.1. Disease breakdown estimates & forecasts, 2018-2027
      • 8.2.1.2. Route of Administration breakdown estimates & forecasts, 2018-2027
      • 8.2.1.3. Therapy Type breakdown estimates & forecasts, 2018-2027
    • 8.2.2. Canada Metabolic Disorder Therapeutics Market
  • 8.3. Europe Metabolic Disorder Therapeutics Market Snapshot
    • 8.3.1. U.K. Metabolic Disorder Therapeutics Market
    • 8.3.2. Germany Metabolic Disorder Therapeutics Market
    • 8.3.3. France Metabolic Disorder Therapeutics Market
    • 8.3.4. Spain Metabolic Disorder Therapeutics Market
    • 8.3.5. Italy Metabolic Disorder Therapeutics Market
    • 8.3.6. Rest of Europe Metabolic Disorder Therapeutics Market
  • 8.4. Asia-Pacific Metabolic Disorder Therapeutics Market Snapshot
    • 8.4.1. China Metabolic Disorder Therapeutics Market
    • 8.4.2. India Metabolic Disorder Therapeutics Market
    • 8.4.3. Japan Metabolic Disorder Therapeutics Market
    • 8.4.4. Australia Metabolic Disorder Therapeutics Market
    • 8.4.5. South Korea Metabolic Disorder Therapeutics Market
    • 8.4.6. Rest of Asia Pacific Metabolic Disorder Therapeutics Market
  • 8.5. Latin America Metabolic Disorder Therapeutics Market Snapshot
    • 8.5.1. Brazil Metabolic Disorder Therapeutics Market
    • 8.5.2. Mexico Metabolic Disorder Therapeutics Market
  • 8.6. Rest of The World Metabolic Disorder Therapeutics Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
  • 9.3. Novo Nordisk
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Eli Lilly and Company
    • 9.3.3. Shire Plc
    • 9.3.4. Sanofi
    • 9.3.5. Merck KGaA
    • 9.3.6. AstraZeneca
    • 9.3.7. AbbVie Inc.,
    • 9.3.8. Actelion Pharmaceuticals Ltd
    • 9.3.9. Amgen Inc.,
    • 9.3.10. Biocon

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Metabolic Disorder Therapeutics Market, report scope
  • TABLE 2. Global Metabolic Disorder Therapeutics Market estimates & forecasts by region 2018-2027 (USD Billion)
  • TABLE 3. Global Metabolic Disorder Therapeutics Market estimates & forecasts by Disease 2018-2027 (USD Billion)
  • TABLE 4. Global Metabolic Disorder Therapeutics Market estimates & forecasts by Route of Administration 2018-2027 (USD Billion)
  • TABLE 5. Global Metabolic Disorder Therapeutics Market estimates & forecasts by Therapy Type 2018-2027 (USD Billion)
  • TABLE 6. Global Metabolic Disorder Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 7. Global Metabolic Disorder Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 8. Global Metabolic Disorder Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 9. Global Metabolic Disorder Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 10. Global Metabolic Disorder Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 11. Global Metabolic Disorder Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 12. Global Metabolic Disorder Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 13. Global Metabolic Disorder Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 14. Global Metabolic Disorder Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 15. Global Metabolic Disorder Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 16. U.S. Metabolic Disorder Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 17. U.S. Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 18. U.S. Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 19. Canada Metabolic Disorder Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 20. Canada Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 21. Canada Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 22. UK Metabolic Disorder Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 23. UK Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 24. UK Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 25. Germany Metabolic Disorder Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 26. Germany Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 27. Germany Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 28. RoE Metabolic Disorder Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 29. RoE Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 30. RoE Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 31. China Metabolic Disorder Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 32. China Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 33. China Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 34. India Metabolic Disorder Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 35. India Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 36. India Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 37. Japan Metabolic Disorder Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 38. Japan Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 39. Japan Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 40. RoAPAC Metabolic Disorder Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 41. RoAPAC Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 42. RoAPAC Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 43. Brazil Metabolic Disorder Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 44. Brazil Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 45. Brazil Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 46. Mexico Metabolic Disorder Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 47. Mexico Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 48. Mexico Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 49. RoLA Metabolic Disorder Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 50. RoLA Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 51. RoLA Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 52. Row Metabolic Disorder Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 53. Row Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 54. Row Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 55. List of secondary sources, used in the study of global Metabolic Disorder Therapeutics Market
  • TABLE 56. List of primary sources, used in the study of global Metabolic Disorder Therapeutics Market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Metabolic Disorder Therapeutics Market, research methodology
  • FIG 2. Global Metabolic Disorder Therapeutics Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Metabolic Disorder Therapeutics Market, key trends 2020
  • FIG 5. Global Metabolic Disorder Therapeutics Market, growth prospects 2021-2027
  • FIG 6. Global Metabolic Disorder Therapeutics Market, porters 5 force model
  • FIG 7. Global Metabolic Disorder Therapeutics Market, pest analysis
  • FIG 8. Global Metabolic Disorder Therapeutics Market, value chain analysis
  • FIG 9. Global Metabolic Disorder Therapeutics Market by segment, 2018 & 2027 (USD Billion)
  • FIG 10. Global Metabolic Disorder Therapeutics Market by segment, 2018 & 2027 (USD Billion)
  • FIG 11. Global Metabolic Disorder Therapeutics Market by segment, 2018 & 2027 (USD Billion)
  • FIG 12. Global Metabolic Disorder Therapeutics Market by segment, 2018 & 2027 (USD Billion)
  • FIG 13. Global Metabolic Disorder Therapeutics Market by segment, 2018 & 2027 (USD Billion)
  • FIG 14. Global Metabolic Disorder Therapeutics Market, regional snapshot 2018 & 2027
  • FIG 15. North America Metabolic Disorder Therapeutics Market 2018 & 2027 (USD Billion)
  • FIG 16. Europe Metabolic Disorder Therapeutics Market 2018 & 2027 (USD Billion)
  • FIG 17. Asia pacific Metabolic Disorder Therapeutics Market 2018 & 2027 (USD Billion)
  • FIG 18. Latin America Metabolic Disorder Therapeutics Market 2018 & 2027 (USD Billion)
  • FIG 19. Global Metabolic Disorder Therapeutics Market, company market share analysis (2020)